Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer
Lin, J.J., Liu, S.V., McCoach, C.E., Zhu, V.W., Tan, A.C., Yoda, S., Peterson, J., Do, A., Prutisto-Chang, K., Dagogo-Jack, I., Sequist, L.V., Wirth, L.J., Lennerz, J.K., Hata, A.N., Mino-Kenudson, M., Nardi, V., Ou, S.-H.I., Tan, D.S.-W., Gainor, J.F.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
Molecular Profiling in Small Cell Lung Cancer and Lung Neuroendocrine Tumors
Feldman, R, Astsaturov, I, Millis, S, Subramaniam, D, Liu, S.V
Published in International journal of radiation oncology, biology, physics (01.11.2014)
Published in International journal of radiation oncology, biology, physics (01.11.2014)
Get full text
Journal Article
2539 A phase II trial of AEZS-108 in castration and taxane resistant prostate cancer
Pinski, J, Schally, A.V, Groshen, S, Denice, T.W, Liu, S.V, Quinn, D, Dorff, T, Athreya, K, Yu, S, Xiong, S
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
A phase 1/1b study of RXDX-105, an oral RET and BRAF inhibitor, in patients with advanced solid tumors
Drilon, A, Marwan, F, Fu, S, Patel, M.R, Olszanski, A.J, Lockhart, A.C, Liu, S.V, Bazhenova, L, Seery, T, Nikolinakos, P, Patel, R, Oliver, J.W, Multani, P.S, Wang, D
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
513 Safety, activity and biomarkers of atezolizumab (MPDL3280A) with platinum-based chemotherapy (chemo) in non-small cell lung cancer (NSCLC): A Phase Ib study
Giaccone, G, Camidge, D.R, Liu, S.V, Powderly, J, Hodi, F.S, Gettinger, S.N, Heist, R.S, Liu, B, Wallin, J, Funke, R, Waterkamp, D, Ready, N.E
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
3088 Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test
Gadgeel, S, Soria, J.C, Goldman, J.W, Wakelee, H, Camidge, D.R, Yu, H, Varga, A, Solomon, B, Oxnard, G.R, Ou, S.H, Papadimitrakopoulou, V, Liu, S.V, Reckamp, K, Spira, A, Piotrowska, Z, Despain, D, Karlovich, C, Yurasov, S, Sequist, L.V
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
29LBA Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements
Siena, S, Drilon, A.E, Sai-Hong Ou, I, Farago, A.F, Patel, M, Bauer, T.M, Hong, D, Liu, S.V, Lee, J, Patel, R, Schechet, L, Luo, D, Chow Maneval, E, Multani, P.S, De Braud, F.G
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
MC13-0020 Targeted next-generation sequencing (NGS) of circulating tumor cells (CTCs) and matched primary tumors
Liu, S.V, Dempsey, P.W, Strauss, W, Xu, Y, Xu, T, Triche, T.J, Quinn, D.I, Goldkorn, A
Published in European journal of cancer (1990) (01.11.2013)
Published in European journal of cancer (1990) (01.11.2013)
Get full text
Journal Article
1452P Factors associated with real-world (rw) outcomes among pts with metastatic NSCLC (mNSCLC) receiving select immuno-oncology (IO) regimens: CORRELATE
Liu, S.V., Salomonsen, R.J-B., Diaz Perez, I., Wang, A., Cai, L., Schmidt, J., Sadow, S., Peters, S.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents
Laskin, J., Liu, S.V., Tolba, K., Heining, C., Schlenk, R.F., Cheema, P., Cadranel, J., Jones, M.R., Drilon, A., Cseh, A., Gyorffy, S., Solca, F., Duruisseaux, M.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial
Mansfield, A.S., Każarnowicz, A., Karaseva, N., Sánchez, A., De Boer, R., Andric, Z., Reck, M., Atagi, S., Lee, J.-S., Garassino, M., Liu, S.V., Horn, L., Wen, X., Quach, C., Yu, W., Kabbinavar, F., Lam, S., Morris, S., Califano, R.
Published in Annals of oncology (01.02.2020)
Published in Annals of oncology (01.02.2020)
Get full text
Journal Article
1052P Comprehensive molecular profiling of squamous non-small cell lung cancer by smoking status
Reuss, J., Gandhi, N., Walker, P., Halmos, B., Aggarwal, C., Xiu, J., Patel, S.P., VanderWalde, A., Ramalingam, S.S., Liu, S.V.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1399P Tumor-immune microenvironment analysis of de novo and acquired KRAS-mutated non-small cell lung cancer
Reuss, J., Gandhi, N., Walker, P., Nieva, J., Bustamante Alvarez, J.G., Carlisle, J., Desai, A., VanderWalde, A.M., Ma, P.C., Liu, S.V.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
Drilon, A., Li, G., Dogan, S., Gounder, M., Shen, R., Arcila, M., Wang, L., Hyman, D.M., Hechtman, J., Wei, G., Cam, N.R., Christiansen, J., Luo, D., Maneval, E.C., Bauer, T., Patel, M., Liu, S.V., Ou, S.H.I., Farago, A., Shaw, A., Shoemaker, R.F., Lim, J., Hornby, Z., Multani, P., Ladanyi, M., Berger, M., Katabi, N., Ghossein, R., Ho, A.L.
Published in Annals of oncology (01.05.2016)
Published in Annals of oncology (01.05.2016)
Get full text
Journal Article
Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
Griesinger, F., Curigliano, G., Thomas, M., Subbiah, V., Baik, C.S., Tan, D.S.W., Lee, D.H., Misch, D., Garralda, E., Kim, D.-W., van der Wekken, A.J., Gainor, J.F., Paz-Ares, L., Liu, S.V., Kalemkerian, G.P., Houvras, Y., Bowles, D.W., Mansfield, A.S., Lin, J.J., Smoljanovic, V., Rahman, A., Kong, S., Zalutskaya, A., Louie-Gao, M., Boral, A.L., Mazières, J.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
EP08.02-098 Phase 2 EVOKE-02 Study of Sacituzumab Govitecan and Pembrolizumab±Platinum in First-Line Metastatic NSCLC
Reck, M., Liu, S.V., Owen, S.P., Garon, E.B., Neal, J.W., Vicente, D., Mekan, S.F., Safavi, F., Fernando, N., Mok, T.S.K.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
105P Pan-tumor survey of ROS1 fusions detected by next-generation RNA sequencing
Zhang, S., Nagasaka, M., Baca, Y., Xiu, J., J.J. Nieva, VanderWalde, A., Swensen, J.J., Spetzler, D., Korn, W.M., Liu, S.V., Ou, S-H.I.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article